The Accord: Generic Event Marketability and Access Agreement Is Now EffectiveNov 15 2012
The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that the Generic Event Marketability and Access Agreement (GEMAA) is now effective.
|
|
The Accord: Generic Event Marketability and Access Agreement is Open for SignatureOct 31 2012
The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that the Generic Event Marketability and Access Agreement (GEMAA) is now open for signature.
|
|
Biotechnology Industry Organization Extends Agreement with VWR International, LLCOct 19 2012
BIO has extended its agreement for over five years with VWR International, LLC, a global distributor of laboratory supplies, equipment, chemicals and services for the life sciences industry. |
|
Registration and Housing for the 2013 BIO International Convention Now AvailableOct 18 2012
The global event for biotech to take place in Chicago, IL April 22-25, 2013.
|
|
BIO President Greenwood Issues Call to Arms to Renewable Energy CommunityOct 18 2012
"Our children’s future rests upon our ability to shift as fast as possible to renewable energy sources. But we won’t succeed unless we can convince our political leaders that renewables are ready, reliable and competitive," Jim Greenwood, President & CEO of BIO, told attendees of RETECH 2012 during a keynote speech.
|
|
BIO Strongly Opposes RFS Waiver Requests in Comments to EPAOct 9 2012
Any waiver of the RFS would have little to no effect on corn prices, but would certainly harm biofuel producers and biotechnology companies across the United States, BIO said today in official comments to the Environmental Protection Agency.
|
|
BIO Pacific Rim Summit to Showcase Role of Biomass in Building Biobased EconomyOct 3 2012
The Biotechnology Industry Organization’s (BIO) 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature breakout sessions focused on using biomass to replace fossil fuels in creating bioenergy, biofuels and other bioproducts.
|
|
BIO Announces Plenary Sessions for 11th Annual BIO Investor ForumOct 3 2012
Sessions to focus on new pharma-VC models for biotech investing, new corporate VC models and forecasting 2013
|
|
PDUFA V Sets New Course for Regulatory Science – Joint BIO/PhRMA StatementOct 1 2012
Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J. Castellani and BIO President and CEO Jim Greenwood released the following joint statement on the implementation of the Prescription Drug User Fee Act (PDUFA V).
|
|
Renewable Fuel Stakeholders Launch National CampaignSep 26 2012
A large coalition of advanced and traditional renewable fuel stakeholders today joined forces to defend America’s Renewable Fuel Standard (RFS) and the economic, employment, domestic renewable energy and national security benefits the RFS provides.
|
